Study illuminates biology behind promising therapy for graft-versus-host disease HealthCanal.com ... Science Translational Medicine, the researchers detail how low doses of the drug interleukin-2 (IL-2) can alleviate chronic graft-versus-host disease (GVHD), a debilitating condition that often occurs in patients who have received a stem cell ... |
